US 12377150
Exon skipping oligomer conjugates for muscular dystrophy
granted A61KA61K47/549A61K47/645
Quick answer
US patent 12377150 (Exon skipping oligomer conjugates for muscular dystrophy) held by Sarepta Therapeutics, Inc. expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K47/549, A61K47/645, A61P, A61P21/00